We aim to make things easy and to keep you informed of your progress every step of the way, from the moment you apply to the receipt of your prescription(s).
The medical cannabis education series continues with Dr Elisabeth Philipps talking to Dr Leon Barron on the role of GPs in treatment and his recent research for Primary Care Cannabis Network.
Catch up via The Sapphire Institute for Medical Cannabis Education.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by a persistent pattern of inattention, hyperactivity-impulsivity, or both. It ...
Throughout history, the cannabis plant has been used for a wide range of therapeutic purposes, including for pain ...
Autism spectrum disorder (ASD) is a developmental brain condition that is now the ninth leading cause of neurological ...
Since November 2018, cannabis-based medicinal products (CBMPs) have been legally available in the UK through specialist doctors. A ...
The use of medical cannabis which includes compounds like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is increasing, particularly among ...
For many patients, medical cannabis is a key part of managing a chronic condition. As access to prescribed ...
Mental health is a vital part of overall wellness, yet for many, accessing effective and timely care remains ...
Seven years ago, on 1 November 2018, the UK took a landmark step forward by legalising medical cannabis ...
Understanding Multiple Sclerosis Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease that affects the central nervous system (CNS). ...
